Mutations in BRCA2—a gene known to repair damaged DNA and suppress tumor formation—can predict an individual's predisposition ...

An indigenously developed CAR T-cell gene therapy has achieved a 73% response rate for certain blood cancers in India. The ...

A new study published in The Lancet Haematology journal says that an indigenously developed gene therapy for certain blood ...

Yale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related ...

Leveraging the power of AI and machine learning technologies, researchers at Weill Cornell Medicine developed a more ...

The data pertains to the company’s lead drug candidate, Reqorsa® Gene Therapy, for the treatment of KRASG12C mutant non-small cell lung cancer (NSCLC) resistant to Ras inhibitors. The study ...

In this interview, News Medical speaks with Olivier Negre, Chief Scientific Officer at Smart Immune, about how immunotherapy ...

A team of Singapore scientists has made a significant discovery in understanding stomach cancer, a disease that remains one ...

Researchers are conducting a groundbreaking trial that could revolutionize the way the body fights cancer, particularly for ...

Although cystic fibrosis is a single gene mutation, there are more than 1,000 different ways the CFTR gene can mutate in ...

In a late-stage trial of patients with multiple types of blood cancer, Orca Bio’s allogeneic T-cell immunotherapy doubled the ...

The American Cancer Society estimates that 83,000 new cases of bladder cancer will be diagnosed this year, with almost 17,000 fatalities. But now, a new gene therapy is giving patients more hope of ...